Navigation Links
Drug a New Weapon Against One Form of Breast Cancer
Date:10/10/2007

Adding paclitaxel to standard chemo targets HER2-positive tumors

WEDNESDAY, Oct. 10 (HealthDay News) -- When added to a standard chemotherapy, the drug paclitaxel (Taxol) cuts the recurrence of breast cancer by 41 percent in women with a particular form of tumor, a new study finds.

Those tumors are called "HER2-positive" because their cells produce an excess of the protein human epidermal growth factor receptor-2 (HER2).

In recent years, cancer specialists have found that breast tumors with different characteristics respond differently to various regimens. The new study adds another piece to that puzzle, experts say.

"Over the last 10 years, we have come to realize that breast cancer isn't one disease but a family of diseases," explained study co-author Dr. Eric Winer, director of the breast oncology center at the Dana-Farber Cancer Institute in Boston. "In this study, what we saw is very different benefits for paclitaxel in different subgroups of women," he said.

"This adds to a growing body of literature" about which chemotherapy regimens benefit which types of tumors, added the study's lead author, Dr. Daniel F. Hayes, clinical director of the breast oncology program at the University of Michigan Comprehensive Cancer Center and professor of internal medicine at the University of Michigan, Ann Arbor.

"We can use the biology of the cancer to select the [appropriate] chemotherapy," he said.

The findings are published in the Oct. 11 issue of the New England Journal of Medicine

The researchers randomly selected 1,500 women from 3,121 patients with lymph node-positive breast cancer, meaning it had spread to nearby lymph nodes; all were part of the Cancer and Leukemia Group B study, a national clinical research effort sponsored by the U.S. National Cancer Institute.

The women had been randomly assigned to get the standard anti-cancer drugs doxorubicin plus cycl
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Smallpox as Biological Weapons?
2. Mouthwash as a weapon
3. New Weapon Against Germs
4. Turmeric and Onions-Weapons against Colon Cancer
5. Researchers Find Secret Weapon Used by SARS Virus
6. A New Weapon Against Obesity
7. Latest Weapon in Battle against Drug-Resistant Bacteria
8. Curcumin –New Weapon Against Colorectal Cance
9. NRI Scientists find Potential Colon Cancer Weapon
10. Battle against Gum Disease Acquires new Weapon
11. Cellular Pathway Yields Potential New Weapon in Vaccine Arsenal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 19, 2014 After a ... performer is again returning to the stage to entertain ... husband for concert performances, and the successful tour has ... originally announced. , Visit Ticketability.com for ... newly-announced Detroit shows at fair prices. , Music fans ...
(Date:12/19/2014)... News) -- A new study suggests a possible link ... flashes and night sweats -- and higher rates of ... common during menopause, affecting about 60 percent of women. ... menopause, since they then face a higher risk of ... who exhibit moderate or severe menopausal symptoms are more ...
(Date:12/19/2014)... News) -- Prostaglandin analogue eye drops -- a common ... of vision loss in patients with the eye disease, ... David Garway-Heath, of the Moorfields Eye Hospital and UCL ... than 500 people newly diagnosed with open-angle glaucoma -- ... of the leading causes of blindness. About 45 ...
(Date:12/17/2014)... December 17, 2014 This prestigious ... practices that have made outstanding and innovative contributions ... and progression of private practice physical therapy by ... Therapy Association. , On behalf of Performance Physical ... and CEO of Performance accepted the award at ...
(Date:12/17/2014)... Now in its second year, the ... the best in senior living and home care across ... communities and agencies that have received outstanding online feedback ... nearly 100,000 providers currently listed on SeniorAdvisor.com, only 879 ... Best of 2015 Awards are located all over the ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 3
... Reporter , THURSDAY, Jan. 5 (HealthDay News) -- Pediatric ... to lower the threshold for toxic lead exposure in ... and house paint, can permanently damage developing brains. ... Poisoning Prevention voted to recommend that the federal government ...
... of patients with mild-to-moderate asthma have persistently non-eosinophilic ... anti-inflammatory treatments, according to a new study. ... enrolled in nine clinical trials conducted by the ... eosinophils) was,found in only 36% of asthmatics not ...
... Mozes HealthDay Reporter , THURSDAY, Jan. 5 ... double their risk of developing a particularly advanced form ... large new European study suggests. The possible link ... (AMD), a significant cause of blindness in seniors. ...
... Proton therapy, a type of external beam radiation therapy, ... according to two new studies published in the January ... (Red Journal), the American Society for Radiation Oncology,s ... study, researchers at the University of Florida in Jacksonville, ...
... Jan. 5 (HealthDay News) -- Children and young adults ... for complications from the flu and should receive flu ... in Ohio in February 2011. Of the 130 ... young adults with neurological and neurodevelopmental conditions, 76 (58 ...
... cost paid for statins (drugs to lower cholesterol) in ... insurance is approximately 400 percent higher than comparable costs ... These findings, from the Boston University School of Medicine ... results of a comprehensive comparison of prescription drug costs ...
Cached Medicine News:Health News:Experts Endorse Lower Lead-Poisoning Threshold 2Health News:Experts Endorse Lower Lead-Poisoning Threshold 3Health News:A large subgroup of mild-to-moderate asthma is persistently non-eosinophilic 2Health News:Could Daily Aspirin Harm Seniors' Eyes? 2Health News:Could Daily Aspirin Harm Seniors' Eyes? 3Health News:Proton therapy effective prostate cancer treatment 2Health News:Study finds statin costs 400 percent higher in US compared to UK 2
(Date:12/19/2014)... Mass. , Dec. 18, 2014  Decision Resources ... the United States will increase to ... will be primarily driven by expansion in the large ... energy devices will be increasingly adopted due to the ... Other key findings from Decision Resources Group,s ...
(Date:12/19/2014)... CITY, Kan. , Dec. 18, 2014 /PRNewswire/ ... PETX ), a biopharmaceutical company focused on the ... companion animals, today announced positive results from its ... innovative drug for treating pain in dogs with ... improvements in pain assessment scores that were statistically ...
(Date:12/17/2014)... 17, 2014 Revenue and earnings above ... research and development In the past 2013/14 fiscal ... two percent to EUR 4.287 billion (last year: EUR 4.190 ... percent to EUR 360 million. "Overall, 2013/14 was a successful ... Kaschke , President and CEO of Carl Zeiss AG. "Thanks ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5ZEISS Asserts its Position in Difficult Environment 2
... 19 Reportlinker.com announces that a new market research ... Production and Market of Xylose in China ... overcapacity and the global financial crisis in Q4 2008, ... small manufacturers suspended or even stopped production due to ...
... YORK, Aug. 19 Reportlinker.com announces that a ... catalogue: Advances in Large Scale ... http://www.reportlinker.com/p0265199/Advances-in-Large-Scale-BioManufacturing-and-Scale-Up-Production-2nd-ED.html A ... of Biopharmaceutical Manufacturing. This new ASM study provides ...
Cached Medicine Technology:Reportlinker Adds Production and Market of Xylose in China 2Reportlinker Adds Production and Market of Xylose in China 3Reportlinker Adds Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED 2Reportlinker Adds Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED 3
... The BD Vacutainer® Safety-Lok™ Blood ... deliver patient care without compromising ... Safety-Lok™ Blood Collection Set with ... with one-handed activation. This product ...
... Omni-Flex System provides the capability ... the middle of surgery while ... the incision. The system is ... stable for large patients while ...
Standard general retractor system. Fully-adjustable to maintain a low profile in any approach and any patient. Blades can be stacked on top of each other in the operative site....
... System represents the most widely accepted ... wide array of retraction components provides ... system for multi-directional exposure of the ... available for specific procedures: IMA Kit ...
Medicine Products: